Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study

Lucy Deng1, Kristine Macartney1, Deepak Gill2

  • 1National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia; The University of Sydney Children's Hospital Westmead Clinical School, NSW, Australia.

Epilepsy & Behavior : E&B
|December 17, 2021
PubMed

Insights

Few first status epilepticus (SE) cases are vaccine-proximate (VP-SE), but these children are younger and hospitalized longer. Improved vaccination plans are needed post-SE.

Area of Science:

  • Pediatric Neurology
  • Vaccinology
  • Epidemiology

Background:

  • Status epilepticus (SE) is a neurological emergency requiring prompt diagnosis and management.
  • The relationship between vaccination and the incidence of SE requires further investigation.
  • Understanding SE in relation to vaccination can inform public health strategies and clinical care.

Purpose of the Study:

  • To determine the proportion of first-time SE cases that occur proximate to vaccination (VP-SE).
  • To compare clinical outcomes, including severity and recurrence, between VP-SE and non-vaccine-proximate SE (NVP-SE) cases.
  • To analyze vaccination coverage rates following SE events.

Main Methods:

  • Probabilistic linkage of birth records (1,440,807 children, 1998-2012) with hospitalization and vaccination data.
  • Categorization of first SE hospitalizations as VP-SE or NVP-SE.
  • Comparison of clinical severity (e.g., ICU admission, coinfection) and 12-month SE recurrence rates between groups.

Main Results:

  • 3.6% of 867 first SE cases were VP-SE; most followed measles vaccine dose 1.
  • VP-SE cases were significantly younger and had longer hospitalizations than NVP-SE cases.
  • ICU admission was associated with coinfection and younger age, not VP-SE; SE recurrence rates were similar, but post-SE vaccine uptake decreased significantly.

Conclusions:

  • While proportionally few SE cases are vaccine-proximate, they present with distinct characteristics, including younger age and higher coinfection rates.
  • Intensive care unit admission in VP-SE is primarily linked to younger age and coinfection, rather than the vaccine proximity itself.
  • There is a critical need for targeted vaccination plans to improve vaccine uptake in children following an SE event.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
350
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
661
Vaccinations01:51

Vaccinations

Overview
45.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
17
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
511
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15